The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics.
By Edmund Sonuga-Barke. Neuroscience and Biobehavioral Reviews, 2003
851 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Cognitive Neuroscience, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/fc5c8e9912dc793431429dad84f3b9c1bf3b5808
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Cognitive Neuroscience
In Psychiatry and Mental health
Citations in the corpus
- Behavioral models of impulsivity in relation to ADHD: Translation between clinical and preclinical studies (2006, neutral): “It has been suggested that this pattern of impulsive choice is indicative of enhanced motivation to escape or avoid delay, and that the inattentive, overactive and impulsive behaviors in which ADHD patients engage are functional expressions of delay-aversion (Sonuga-Barke, 2002, 2003).”
- Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis (2007, background): “The involvement of the cerebellum (see Nigg & Casey, 2005) and the dual pathways defined by ventral and dorsal component of the striatum (Sonuga-Barke, 2003) are probably necessary for a full account of modulation of activity by dopamine and other neurotransmitters.”
- The Catechol-O-Methyltransferase Polymorphism: Relations to the Tonic–Phasic Dopamine Hypothesis and Neuropsychiatric Phenotypes (2004, background): “It is interesting in this respect that Sonuga-Bark distinguished two types of deficit in ADHD that are independent: one a ‘cognitive’ inhibition deficit putatively related to mesocortical DA and the other a ‘reward’ sensitivity deficit putatively linked to mesolimbic DA (Sonuga-Barke, 2003).”
- The role of impulsive behavior in drug abuse (2008, background): “Performance on laboratory measures of impulsive choice and inhibition are not necessarily related in humans (Dalen et al. 2004; Solanto et al. 2001; Sonuga-Barke 2003; Sonuga-Barke et al. 2003) or rats (Van den Bergh et al.”
- Evaluating Dopamine Reward Pathway in ADHD (2009, neutral): “The DSM-IV ADHD items were assessed using the Strengths and Weaknesses of ADHD-symptoms and Normal-behavior (SWAN) rating scale, which uses a positive scale for symptoms (1 to 3) and a negative scale for the opposite of the symptoms (−1 to −3) ranging from far belowaverage to faraboveaverage.21 This”